Skip to content

Compare medicines

Put up to three medicines side by side. Useful for alternatives in the same class, or for seeing how two very different treatments differ.

Attribute
In shortDiabetes tablet that makes the kidneys pass out extra sugar.SGLT2 inhibitor for diabetes, heart failure and kidney disease.
Body systemDiabetes & WeightDiabetes & Weight
Drug classSGLT2 inhibitorsSGLT2 inhibitors
SupplyPrescription onlyPrescription only
Main usesType 2 diabetes, Diabetic kidney disease, Heart failure risk reductionType 2 diabetes, Heart failure (all ejection fractions), Chronic kidney disease
How it worksStops the kidneys reclaiming some filtered sugar, so it leaves in urine.Pushes excess sugar and salt out through the urine.
Starts working——
Half-life—About 13 hours
Typical adult doseUsually 100 mg once daily before the first meal; some people may increase to 300 mg if kidney function allows.10 mg once a day.
FormsTabletTablet, Combination tablets
Common side effectsGenital thrush, Increased urination, DehydrationGenital thrush, Urinary infections, Back pain
Serious side effectsDiabetic ketoacidosis, Severe urinary or genital infection, Amputation risk in selected high-risk patientsKetoacidosis, Dehydration, Fournier's gangrene (rare)
Don't take if—Type 1 diabetes (risk of ketoacidosis); Severe dehydration or ongoing vomiting; Recurrent genital or urinary infections
Alcohol—Best to limit. Heavy drinking raises the risk of ketoacidosis.
PregnancyUsually avoidedNot recommended during pregnancy because fetal kidney development may be affected.Usually avoidedNot recommended.
Breastfeeding—Usually avoidedAvoid.
In use since—2012
Brand namesUnited States: InvokanaUnited Kingdom: InvokanaUnited States: FarxigaUnited Kingdom: ForxigaIndia: Forxiga, Oxra, Udapa
Legal status—United States: Prescription onlyUnited Kingdom: Prescription-only medicine (POM)India: Schedule H
ATC codeA10BK02A10BK01

Taken together

No interaction between these medicines is recorded in the atlas.

Open in the interaction checker